Most Windows 11 users rely on the Windows Security graphical interface to run antivirus scans, but the command line offers a faster and more flexible alternative — especially when the GUI is ...

AUSTIN, Texas — Nine new businesses have been granted conditional cannabis dispensary licenses as Texas expands its Compassionate Use Program for medical marijuana. The new companies include Central ...

Actor David Hasselhoff was spotted utilizing a walker during a public outing, an appearance representatives clarified is due to the actor recovering from knee and hip replacement surgeries. The ...

EDMONDS, Wash. — Syreh Sonko is studying nursing at Edmonds College through Washington state's Running Start, but the program that's saving her nearly $30,000 in college costs may soon look different.

The Army will kick off its new retention bonus system next month, using physical fitness scores, technical expertise and commander evaluations to determine a soldier’s payout to reenlist. “We were ...

The Seattle Times’ Education Lab examines the educational system from early childhood through post-secondary. Education Lab is supported by Gates Foundation, Ballmer Group and The Norcliffe Foundation ...

I can't stand opening the Microsoft Store. It's slow to load, confusing to browse, and full of ads for things I don't care about. Luckily, thanks to a new feature, I don't have to open the Microsoft ...

Federal Communications Commission Chair Brendan Carr is urging broadcast media companies to air “patriotic, pro-America content” in a new campaign aligned with President Donald Trump’s Freedom 250 ...

When students talk about the ability to take Running Start courses during the summer, they don’t talk about credits; they talk about opportunity. For one high school student, enrolling in a summer ...

Hey there, fellow coder! 😊 Ever typed java -version in your Command Prompt only to be hit with a frustrating "java is not recognized as an internal or external command"? You're not alone—this common ...

Amgen has terminated its rocatinlimab collaboration with Kyowa Kirin, walking away from the anti-OX40 antibody five years after paying $400 million for rights to the autoimmune disease drug candidate.